CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

Koji Shinoda, Yasunobu Yoshikai

    Research output: Contribution to journalComment/debatepeer-review

    Original languageEnglish
    Pages (from-to)111-112
    Number of pages2
    JournalClinical and Experimental Neuroimmunology
    Issue number2
    Publication statusPublished - May 1 2015

    All Science Journal Classification (ASJC) codes

    • Neuroscience (miscellaneous)
    • Immunology
    • Immunology and Microbiology (miscellaneous)
    • Clinical Neurology

    Cite this